About the Authors
- Xiomara V. Thomas
-
Contributed equally to this work with: Xiomara V. Thomas, Joep de Bruijne
* E-mail: x.v.thomas@amc.uva.nl
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands
- Joep de Bruijne
-
Contributed equally to this work with: Xiomara V. Thomas, Joep de Bruijne
Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
- James C. Sullivan
-
Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America
- Tara L. Kieffer
-
Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America
- Cynthia K. Y. Ho
-
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands
- Sjoerd P. Rebers
-
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands
- Michel de Vries
-
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Human Retro Virology, Amsterdam, The Netherlands
- Hendrik W. Reesink
-
Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
- Christine J. Weegink
-
Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
- Richard Molenkamp
-
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands
- Janke Schinkel
-
Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands
Competing Interests
The authors have read the journal's policy and have the following conflicts: HR serves as advisor for Roche Molecular Diagnostics, Anadys, Merck, Arrows, and Gilead, consults for PRA-International, Tibotec, GlaxoSmithKline, Chiron Novartis, and Roche Therapeutics, and receives grant/research support from Merck & Co. TK and J. Sullivan are employees and stock owners of Vertex Pharmaceuticals Incorporated. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have nothing to disclose.
Author Contributions
Conceived and designed the experiments: XVT JdB J. Schinkel RM HR. Performed the experiments: XVT SPR. Analyzed the data: XVT RM J. Schinkel CKYH TK J. Sullivan. Contributed reagents/materials/analysis tools: MdV RM TK J. Sullivan. Wrote the paper: XVT JdB J. Schinkel. Helped with study set-up: CJW.